These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28888558)

  • 1. Elimination of hepatitis C virus infection among PWID: The beginning of a new era of interferon-free DAA therapy.
    Grebely J; Bruneau J; Bruggmann P; Harris M; Hickman M; Rhodes T; Treloar C; ;
    Int J Drug Policy; 2017 Sep; 47():26-33. PubMed ID: 28888558
    [No Abstract]   [Full Text] [Related]  

  • 2. Restrictions on access to direct-acting antivirals for people who inject drugs: The European Hep-CORE study and the role of patient groups in monitoring national HCV responses.
    Lazarus JV; Safreed-Harmon K; Stumo SR; Jauffret-Roustide M; Maticic M; Reic T; Schatz E; Tallada J; Harris M;
    Int J Drug Policy; 2017 Sep; 47():47-50. PubMed ID: 28689856
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment cascade for hepatitis C virus in young adult people who inject drugs in San Francisco: Low number treated.
    Morris MD; Mirzazadeh A; Evans JL; Briceno A; Coffin P; Hahn JA; Page KA
    Drug Alcohol Depend; 2019 May; 198():133-135. PubMed ID: 30921649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eligibility of persons who inject drugs for treatment of hepatitis C virus infection.
    Arain A; Robaeys G
    World J Gastroenterol; 2014 Sep; 20(36):12722-33. PubMed ID: 25278674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies to Reduce Hepatitis C Virus Reinfection in People Who Inject Drugs.
    Martinello M; Dore GJ; Matthews GV; Grebely J
    Infect Dis Clin North Am; 2018 Jun; 32(2):371-393. PubMed ID: 29778261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prisons, prisoners, and hepatitis C.
    Ferguson L; Batey R
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1184-6. PubMed ID: 20594243
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study.
    Bajis S; Grebely J; Hajarizadeh B; Applegate T; Marshall AD; Ellen Harrod M; Byrne J; Bath N; Read P; Edwards M; Gorton C; Hayllar J; Cock V; Peterson S; Thomson C; Weltman M; Jefferies M; Wood W; Haber P; Ezard N; Martinello M; Maher L; Dore GJ;
    J Viral Hepat; 2020 Mar; 27(3):281-293. PubMed ID: 31698545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antiviral treatment for hepatitis C among injecting drug users in the era of direct-acting antiviral agents].
    Pan L; Pang L
    Zhonghua Gan Zang Bing Za Zhi; 2020 Oct; 28(10):893-896. PubMed ID: 33105938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are Interferon-Free Direct-Acting Antivirals for the Treatment of HCV Enough to Control the Epidemic among People Who Inject Drugs?
    Lima VD; Rozada I; Grebely J; Hull M; Lourenco L; Nosyk B; Krajden M; Yoshida E; Wood E; Montaner JS
    PLoS One; 2015; 10(12):e0143836. PubMed ID: 26633652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elimination on the agenda for hepatitis C.
    Burki T
    Lancet Infect Dis; 2014 Jun; 14(6):452-3. PubMed ID: 24971446
    [No Abstract]   [Full Text] [Related]  

  • 11. Mitigating the burden of hepatitis C virus among people who inject drugs in Belgium.
    Matheï C; Bourgeois S; Blach S; Brixko C; Mulkay JP; Razavi H; Robaeys G
    Acta Gastroenterol Belg; 2016; 79(2):227-32. PubMed ID: 27382943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosocial Factors and the Care Cascade for Hepatitis C Treatment Colocated at a Syringe Service Program.
    Winetsky D; Burack D; Antoniou P; Garcia B; Gordon P; Scherer M
    J Infect Dis; 2020 Sep; 222(Suppl 5):S392-S400. PubMed ID: 32877544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing hepatitis C treatment uptake and outcomes for injection drug users.
    Dore GJ
    Hepatology; 2007 Jan; 45(1):3-5. PubMed ID: 17187427
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis C virus reinfection after successful treatment with direct-acting antiviral therapy in a large population-based cohort.
    Rossi C; Butt ZA; Wong S; Buxton JA; Islam N; Yu A; Darvishian M; Gilbert M; Wong J; Chapinal N; Binka M; Alvarez M; Tyndall MW; Krajden M; Janjua NZ;
    J Hepatol; 2018 Nov; 69(5):1007-1014. PubMed ID: 30142429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention, treatment and care of hepatitis C virus infection among people who inject drugs.
    Bruggmann P; Grebely J
    Int J Drug Policy; 2015 Feb; 26 Suppl 1():S22-6. PubMed ID: 25245939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C treatment for injection drug users: a review of the available evidence.
    Hellard M; Sacks-Davis R; Gold J
    Clin Infect Dis; 2009 Aug; 49(4):561-73. PubMed ID: 19589081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Injection drug users can be effectively treated for hepatitis C.
    Stancliff S
    Am Fam Physician; 2011 Mar; 83(6):647; author reply 648. PubMed ID: 21404974
    [No Abstract]   [Full Text] [Related]  

  • 18. Modelling the elimination of hepatitis C as a public health threat in Iceland: A goal attainable by 2020.
    Scott N; Ólafsson S; Gottfreðsson M; Tyrfingsson T; Rúnarsdóttir V; Hansdottir I; Hernandez UB; Sigmundsdóttir G; Hellard M
    J Hepatol; 2018 May; 68(5):932-939. PubMed ID: 29274408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling indicates efficient vaccine-based interventions for the elimination of hepatitis C virus among persons who inject drugs in metropolitan Chicago.
    Echevarria D; Gutfraind A; Boodram B; Layden J; Ozik J; Page K; Cotler SJ; Major M; Dahari H
    Vaccine; 2019 May; 37(19):2608-2616. PubMed ID: 30962092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "I'm obviously not dying so it's not something I need to sort out today": Considering hepatitis C treatment in the era of direct acting antivirals.
    Wright C; Cogger S; Hsieh K; Goutzamanis S; Hellard M; Higgs P
    Infect Dis Health; 2019 May; 24(2):58-66. PubMed ID: 30541692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.